Companies / Ocugenix
Ocugenix
Company
Ocugenix develops therapies for eye diseases such as wet macular degeneration, geographic atrophy, and diabetic retinopathy
Ocugenix has 1 investor on file, among them Mountain State Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Mountain State Capital
18 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (31%), Fintech (15%), Industrial & Manufacturing (12%).
See Mountain State Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Ocugenix and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Mountain State Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/ocugenix.com/investors
# also
GET /v1/companies/ocugenix.com
GET /v1/companies/ocugenix.com/news